Resona Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 29.54%
- Profit Growth 314.92%
- Ebitda 294.03%
- Net Worth 119.74%
- Total Assets 1.19%
About Resona Pharmaceutical
Resona Pharmaceutical Limited (RPL) is a Public Limited Indian Non-Government Company incorporated in India on 23 March 2021 (Three years and 11 months 26 days old ). Its registered office is in Salem, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Duraisami Sathishkannan, Suresh Vijay, and Kuppuraj Shanmugavadivu serve as directors at the Company.
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33110TZ2021PLC035879
- Company No.
035879
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Pharma
Resona Pharmaceutical Limited
Explore comprehensive data for Resona Pharmaceutical Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Resona Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Duraisami Sathishkannan  | Director | 23-Mar-2021 | Current |
| Suresh Vijay | Director | 23-Mar-2021 | Current |
| Kuppuraj Shanmugavadivu | Director | 23-Mar-2021 | Current |
Financial Performance of Resona Pharmaceutical.
Resona Pharmaceutical Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.54% increase. The company also saw a substantial improvement in profitability, with a 314.92% increase in profit. The company's net worth Soared by an impressive increase of 119.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Resona Pharmaceutical?
In 2023, Resona Pharmaceutical had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Velova Coal And Eco Power India Private LimitedDuraisami Sathishkannan is a mutual person
Swarnakoviyal Jewellers And Services LimitedDuraisami Sathishkannan is a mutual person
Finxsoftware LimitedDuraisami Sathishkannan and Kuppuraj Shanmugavadivu are mutual person
Clazy Airways LimitedDuraisami Sathishkannan, Suresh Vijay and 1 more are mutual person
Clazy Smartinco Services LimitedDuraisami Sathishkannan, Suresh Vijay and 1 more are mutual person
Clazy Pension Tree LimitedDuraisami Sathishkannan, Suresh Vijay and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Resona Pharmaceutical?
Resona Pharmaceutical has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Resona Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Resona Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Resona Pharmaceutical
Recent activity within the organization
- Annual General Meeting
Resona Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Resona Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Coimbatore.
- Director Appointment
Duraisami Sathishkannan was appointed as a Director was appointed as a Director on 23 Mar 2021 & has been associated with this company since 3 years 11 months .
- Director Appointment
Suresh Babu Roshan Vijay was appointed as a Director was appointed as a Director on 23 Mar 2021 & has been associated with this company since 3 years 11 months .
- Director Appointment
Kuppuraj Shanmugavadivu was appointed as a Director was appointed as a Director on 23 Mar 2021 & has been associated with this company since 3 years 11 months .
- Company Incorporation
Resona Pharmaceutical Limited was registered on 23 Mar 2021 with Roc Coimbatore & aged 3 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Resona Pharmaceutical Limited?
Resona Pharmaceutical Limited was incorporated on 23 Mar 2021.
What is authorized share capital and paid-up capital of Resona Pharmaceutical Limited?
The authorized share capital of Resona Pharmaceutical Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Resona Pharmaceutical Limited?
Currently 3 directors are associated with Resona Pharmaceutical Limited.
- Duraisami Sathishkannan
- Suresh Babu Roshan Vijay
- Kuppuraj Shanmugavadivu
What is the registered address of Resona Pharmaceutical Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Resona Pharmaceutical Limited is 253/8 Arun Nagar Annexe Iyer Thottam Periyapuddur, India, Salem, Tamil Nadu, 636016.
What is the corporate identification number (CIN) and company number of Resona Pharmaceutical Limited?
The corporate identification number (CIN) of Resona Pharmaceutical Limited is U33110TZ2021PLC035879 and the company number is 035879 as per Ministry of Corporate Affairs (MCA).
What is the official website of Resona Pharmaceutical Limited?
The Official website of Resona Pharmaceutical Limited is https://www.resonapharma.com
What has been the recent revenue trend for Resona Pharmaceutical Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Resona Pharmaceutical Limited has risen by 29.54%.
What change has been observed in the net worth of Resona Pharmaceutical Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Resona Pharmaceutical Limited has experienced an upsurge of 119.74%.
When was the last Balance Sheet of Resona Pharmaceutical Limited filed with the ROC?
The most recent Balance Sheet for Resona Pharmaceutical Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records